NDC 0053-7670

Albuminar-5

Albumin (human)

Albuminar-5 is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Csl Behring Llc. The primary component is Albumin Human.

Product ID0053-7670_044bcbff-83d2-44b4-85c1-de9d156f8a3e
NDC0053-7670
Product TypePlasma Derivative
Proprietary NameAlbuminar-5
Generic NameAlbumin (human)
Dosage FormSolution
Route of AdministrationINTRAVENOUS
Marketing Start Date2009-01-06
Marketing CategoryBLA / BLA
Application NumberBLA103955
Labeler NameCSL Behring LLC
Substance NameALBUMIN HUMAN
Active Ingredient Strength3 g/50mL
Pharm ClassesHuman Serum Alb
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0053-7670-06

1 VIAL, GLASS in 1 CARTON (0053-7670-06) > 50 mL in 1 VIAL, GLASS (0053-7670-90)
Marketing Start Date2009-01-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0053-7670-92 [00053767092]

Albuminar-5 SOLUTION
Marketing CategoryBLA
Application NumberBLA103955
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2013-08-06
Marketing End Date2019-02-17

NDC 0053-7670-32 [00053767032]

Albuminar-5 SOLUTION
Marketing CategoryBLA
Application NumberBLA103955
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2009-01-06
Marketing End Date2019-02-17

NDC 0053-7670-91 [00053767091]

Albuminar-5 SOLUTION
Marketing CategoryBLA
Application NumberBLA103955
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2013-08-06
Marketing End Date2019-02-17

NDC 0053-7670-31 [00053767031]

Albuminar-5 SOLUTION
Marketing CategoryBLA
Application NumberBLA103955
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2009-01-06
Marketing End Date2019-02-17

NDC 0053-7670-90 [00053767090]

Albuminar-5 SOLUTION
Marketing CategoryBLA
Application NumberBLA103955
Product TypePLASMA DERIVATIVE
Marketing Start Date2013-08-06
Marketing End Date2019-02-17

NDC 0053-7670-06 [00053767006]

Albuminar-5 SOLUTION
Marketing CategoryBLA
Application NumberBLA103955
Product TypePLASMA DERIVATIVE
Marketing Start Date2009-01-06
Marketing End Date2019-02-17

Drug Details

Active Ingredients

IngredientStrength
ALBUMIN HUMAN2.5 g/50mL

Pharmacological Class

  • Human Serum Albumin [EPC]
  • Increased Intravascular Volume [PE]
  • Increased Oncotic Pressure [PE]
  • Osmotic Activity [MoA]
  • Serum Albumin [Chemical/Ingredient]

NDC Crossover Matching brand name "Albuminar-5" or generic name "Albumin (human)"

NDCBrand NameGeneric Name
0053-7670Albuminar-5Albumin (Human)
0053-7680Albuminar-25Albumin (Human)
44206-251AlbuRxALBUMIN (HUMAN)
44206-310ALBURXALBUMIN (HUMAN)
68516-5214ALBUTEINALBUMIN (HUMAN)
68516-5215ALBUTEINALBUMIN (HUMAN)
68516-5216ALBUTEINALBUMIN (HUMAN)
61953-0001HUMAN ALBUMIN GRIFOLSALBUMIN (HUMAN)
61953-0002HUMAN ALBUMIN GRIFOLSALBUMIN (HUMAN)
13533-683PlasbuminAlbumin (Human)
13533-684PlasbuminAlbumin (Human)
13533-690PlasbuminAlbumin (Human)
13533-691PlasbuminAlbumin (Human)
13533-692PlasbuminAlbumin (Human)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.